SEC Filing Summary: Global Medical REIT Inc. (Form 10-Q, Q1 2024)
Registrant mismatch: The request identifies Chiron Real Estate Inc., but the supplied filing is for Global Medical REIT Inc. (NYSE: GMRE; Commission file no. 001-37815). Confirm that this is the intended filing before relying on this summary.
Business context and reporting period
This unaudited report covers the three months ended March 31, 2024, with balance-sheet comparisons to December 31, 2023 and operating comparisons to Q1 2023. Global Medical REIT owns and leases healthcare facilities, primarily under medium- to long-term leases. At quarter-end, it reported 185 buildings, 4.75 million leasable square feet, and $110.5 million of annualized base rent. The company owned 92.44% of its operating partnership.
Financial performance and position
Unless otherwise stated, dollar amounts below are in millions.
| Metric | Q1 2024 | Q1 2023 / prior date |
|---|---|---|
| Total revenue | $35.1 | $36.2 |
| Net income | $2.3 | $2.2 |
| Net income attributable to common stockholders | $0.8; $0.01 per share | $0.7; $0.01 per share |
| FFO per share and unit | $0.21 | $0.22 |
| AFFO per share and unit | $0.23 | $0.23 |
| Net cash provided by operating activities | $14.3 | $15.8 |
| Cash and restricted cash | $7.8 | $6.7 at Dec. 31, 2023 |
| Total debt, net | $617.8 | $611.2 at Dec. 31, 2023 |
| Total equity, including noncontrolling interest | $597.1 | $605.8 at Dec. 31, 2023 |
Interest expense was $6.9 million, down from $8.3 million. The weighted-average debt interest rate was 3.85% at quarter-end; weighted-average debt term was 2.7 years. Cash used in investing activities was $2.7 million, mainly for property capital expenditures and leasing commissions; cash used in financing activities was $10.5 million, including common and preferred distributions. The common dividend was $0.21 per share for the quarter; the Series A preferred dividend was $0.46875 per share.
Material changes versus the prior comparable period
- Revenue fell $1.1 million, primarily reflecting three property sales completed in 2023; no acquisitions or dispositions occurred in Q1 2024.
- Net income increased $0.1 million despite the prior-year period including a $0.5 million property-sale gain. Lower interest expense and lower depreciation and amortization helped offset lower revenue.
- General and administrative expense rose $0.6 million, including higher non-cash LTIP compensation expense.
- FFO per share and unit declined from $0.22 to $0.21, while AFFO per share and unit remained $0.23.
- Operating cash flow decreased $1.5 million year over year. Cash and restricted cash increased from year-end, partly due to net credit-facility borrowings.
Outlook, risks, contingencies, and unusual items
- Guidance: The filing provides no specific earnings or FFO guidance. Management expects liquidity needs to be met through operating cash flow, debt and equity financing, property dispositions, and other capital transactions. A $300 million at-the-market equity program was established in January; no shares had been sold through May 6, 2024.
- Potential acquisition: In May 2024, the company agreed to acquire a fully occupied, 15-property outpatient medical portfolio for $81.3 million, subject to customary conditions. It expected closings in two tranches in Q3 and Q4 2024; completion is not assured.
- Tenant bankruptcy: Steward Health Care filed for Chapter 11 on May 6, 2024, after the reporting period. Steward represented 2.8% of annualized base rent; the company reported a $0.5 million receivable, including $0.2 million of deferred rent. Recovery and re-leasing of the Beaumont, Texas facility are uncertain.
- Debt and interest rates: The company had $98.6 million of unhedged variable-rate revolver borrowings. Management estimated a 100-basis-point SOFR increase would reduce annual cash flow by about $1.0 million, assuming debt levels stay constant. The company had $290 million of unused revolver capacity as of May 6 and said it complied with its credit covenants at March 31.
- Near-term obligations: Approximately $11 million of principal on the Dumfries loan matures in June 2024. Capital improvement commitments were approximately $19.6 million, with about $13.9 million expected in the next 12 months, although timing is uncertain.
- Operating risks: Management cited persistently elevated interest rates and healthcare wage inflation, as well as tenant rent collection, reimbursement, vacancy, refinancing, capital-raising, and REIT-qualification risks. Interest-rate swap fair value increased $4.2 million in Q1 and was recorded through other comprehensive income, not operating income.
- Contingencies and controls: The company reported no material litigation or known material environmental liability and no material changes to previously disclosed risk factors. Management concluded disclosure controls were effective as of March 31, 2024.
Important facts for investors to verify
- Confirm the registrant identity: the supplied filing is Global Medical REIT Inc., not Chiron Real Estate Inc.
- Review Steward’s bankruptcy proceedings, rent status, receivable recovery, and the outcome of re-leasing the Beaumont facility.
- Track repayment or refinancing of the Dumfries loan due June 2024 and compliance with credit-facility covenants.
- Assess whether operating cash flow and available borrowing capacity can support dividends, debt service, capital commitments, and any planned acquisition.
- Verify the status, financing, and closing conditions of the proposed $81.3 million portfolio acquisition and whether the ATM program is used.
- Interpret FFO and AFFO as supplemental non-GAAP measures, not substitutes for GAAP earnings or operating cash flow.